ProTECT Clinical Trial Study: What is Traumatic Brain Injury or TBI?

Henry Ford Hospital will evaluate the effectiveness of using the hormone progesterone to treat traumatic brain injuries without first obtaining patients' informed consent as part of a national research study. Called ProTECT, the study aims to determine if progesterone can decrease the disability and death associated with TBI, the leading cause of death and disability in children and adults under age 44, according to the Brain Trauma Foundation. In this video, Dr. Tamar Abdelhak explains TBI, its causes and treatments. Read more about ProTECT at www.docintheD.com

About Henry Ford Health System

Henry Ford Health System (HFHS) is a Michigan not-for-profit corporation governed by a 22-member Board of Trustees. Advisory and affiliate boards comprising 129 Trustee volunteer leaders provide vital links to the communities served by the System. HFHS is managed by Chief Executive Officer Nancy M. Schlichting.

HFHS is one of the nation's leading comprehensive, integrated health systems. It provides health insurance and health care delivery, including acute, specialty, primary and preventive care services backed by excellence in research and education. For more information, visit http://www.henryford.com

Category:

Science & Technology

Tags:

• ProTECT
• traumatic brain injury
• rat
• study
• no informed consent
• er
• brain injury
• emergency
• informed consent
• progesterone
• treatment
• brain
• injury
• trauma
• TBI
• Henry Ford Health System
• Henry Ford
• Detroit Hospital
• Michigan Hospital
• Medical education
• Research Hospital